Head of Corporate Development & Strategy (Pharmaceuticals & Biotechnology) Full Time NEW

Company Description

Galvanized Search specializes in identifying and delivering business-critical talent to the most innovative industries worldwide, with a focus on the life science and healthcare sectors. Renowned for our efficient recruitment methods, we connect leading organizations with top-tier professionals in record time, leveraging a relentless and client-focused approach. As a minority and veteran-owned company, we are passionate about fostering diversity and inclusion within the workforce. Our dedication to providing exceptional service ensures long-term partnerships built on trust and success.

Role Description

As the Head of Corporate Development & Strategy in the therapeutics area, you will lead strategic initiatives, including mergers and acquisitions, business evaluations, relationship management, and growth strategies. Reporting to the CFO, you will be responsible for leading, identifying, evaluating and executing business opportunities that align with our company’s strategy and objectives. This full-time remote role entails managing high-impact projects, conducting due diligence, developing financial models, and navigating complex negotiations to drive successful transactions. You will collaborate with senior leadership to identify growth opportunities, align corporate development plans with organizational objectives, and manage cross-functional teams to execute key deals.

Qualifications

Bachelor’s degree in a relevant field, advanced degree (MBA, PhD) preferred.

• Prior Experience in either Management Consulting or Investment Banking is preferred

• Pharmaceutical or biotechnology industry experience with exposure to business development / licensing is a must.

• Proven track record of successfully negotiating and closing complex deals, including licensing agreements, partnerships, and acquisitions.

• experience negotiating co-development deals or research partnerships is a must
• experience doing outreach to pharma companies, ideally related to early stage / development partnership types of deals